Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain-Reference-Cited by-同舟云学术

Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain

Published:2022-02-28 Issue:5 Volume:38 Page:343-350
ISSN:1536-5409
Container-title:The Clinical Journal of Pain
language:en
Short-container-title:

Author:

Han Kyung Ah,Lee Yong-Ho,Son Hyun-Shik,Song Ki-Ho,Kim Sang Yong,Chung Choon Hee,Jang Hak Chul,Lee Kwan-Woo,Cha Bong Yun,Song Kee-Ho,Ko Young Kwon,Lee Pyung-Bok,Kim Beom Joon,Kim Sohee,An Taewon,Kim Yong-Chul

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference25 articles.

1. Epidemiology of neuropathic pain and its impact on quality of life;Smith;Curr Pain Headache Rep,2012

2. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs;Dworkin;J Pain,2010

3. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options;Veves;Pain Med,2008

4. Pain and its persistence in herpes zoster;Dworkin;Pain,1996

5. Post-herpetic neuralgia: 208 cases;Watson;Pain,1988

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 4 randomized active-controlled clinical study to compare the efficacy and safety of sustained-release pregabalin with immediate-release pregabalin in type 2 diabetic patients with peripheral neuropathic pain;Journal of Diabetes and its Complications;2024-08

2. Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials;International Journal of Molecular Sciences;2023-08-20

3. An analysis and visualization of postherpetic neuralgia research between 1985 and 2022 using scientometrics;2023-07-26

4. A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain;Medicine;2023-04-25

5. Pharmacokinetic properties of a new sustained-release pregabalin tablet in subjects with reduced renal function;Translational and Clinical Pharmacology;2023